nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Urine abnormality—Arformoterol—chronic obstructive pulmonary disease	0.0497	0.0497	CcSEcCtD
Capreomycin—Urine abnormality—Formoterol—chronic obstructive pulmonary disease	0.0497	0.0497	CcSEcCtD
Capreomycin—Foetor hepaticus—Montelukast—chronic obstructive pulmonary disease	0.0475	0.0475	CcSEcCtD
Capreomycin—Urine analysis abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0468	0.0468	CcSEcCtD
Capreomycin—Urine analysis abnormal—Formoterol—chronic obstructive pulmonary disease	0.0468	0.0468	CcSEcCtD
Capreomycin—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.0395	0.0395	CcSEcCtD
Capreomycin—Abscess—Arformoterol—chronic obstructive pulmonary disease	0.0348	0.0348	CcSEcCtD
Capreomycin—Abscess—Formoterol—chronic obstructive pulmonary disease	0.0348	0.0348	CcSEcCtD
Capreomycin—Leukocytosis—Arformoterol—chronic obstructive pulmonary disease	0.0293	0.0293	CcSEcCtD
Capreomycin—Leukocytosis—Formoterol—chronic obstructive pulmonary disease	0.0293	0.0293	CcSEcCtD
Capreomycin—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.0269	0.0269	CcSEcCtD
Capreomycin—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.0239	0.0239	CcSEcCtD
Capreomycin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0213	0.0213	CcSEcCtD
Capreomycin—Abscess—Prednisolone—chronic obstructive pulmonary disease	0.0188	0.0188	CcSEcCtD
Capreomycin—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.0187	0.0187	CcSEcCtD
Capreomycin—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.0182	0.0182	CcSEcCtD
Capreomycin—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.0182	0.0182	CcSEcCtD
Capreomycin—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.0172	0.0172	CcSEcCtD
Capreomycin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.0167	0.0167	CcSEcCtD
Capreomycin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0154	0.0154	CcSEcCtD
Capreomycin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0142	0.0142	CcSEcCtD
Capreomycin—Abscess—Prednisone—chronic obstructive pulmonary disease	0.0137	0.0137	CcSEcCtD
Capreomycin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Capreomycin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Capreomycin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Capreomycin—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.0115	0.0115	CcSEcCtD
Capreomycin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Capreomycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Capreomycin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Capreomycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00966	0.00966	CcSEcCtD
Capreomycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0095	0.0095	CcSEcCtD
Capreomycin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00941	0.00941	CcSEcCtD
Capreomycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00896	0.00896	CcSEcCtD
Capreomycin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00839	0.00839	CcSEcCtD
Capreomycin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00839	0.00839	CcSEcCtD
Capreomycin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00822	0.00822	CcSEcCtD
Capreomycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00813	0.00813	CcSEcCtD
Capreomycin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00812	0.00812	CcSEcCtD
Capreomycin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00792	0.00792	CcSEcCtD
Capreomycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00779	0.00779	CcSEcCtD
Capreomycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00779	0.00779	CcSEcCtD
Capreomycin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00775	0.00775	CcSEcCtD
Capreomycin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00775	0.00775	CcSEcCtD
Capreomycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00766	0.00766	CcSEcCtD
Capreomycin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00766	0.00766	CcSEcCtD
Capreomycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00763	0.00763	CcSEcCtD
Capreomycin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.0076	0.0076	CcSEcCtD
Capreomycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00736	0.00736	CcSEcCtD
Capreomycin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00732	0.00732	CcSEcCtD
Capreomycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00723	0.00723	CcSEcCtD
Capreomycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00723	0.00723	CcSEcCtD
Capreomycin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00715	0.00715	CcSEcCtD
Capreomycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00708	0.00708	CcSEcCtD
Capreomycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00682	0.00682	CcSEcCtD
Capreomycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00619	0.00619	CcSEcCtD
Capreomycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00619	0.00619	CcSEcCtD
Capreomycin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00618	0.00618	CcSEcCtD
Capreomycin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00618	0.00618	CcSEcCtD
Capreomycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00606	0.00606	CcSEcCtD
Capreomycin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00605	0.00605	CcSEcCtD
Capreomycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00585	0.00585	CcSEcCtD
Capreomycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00584	0.00584	CcSEcCtD
Capreomycin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00583	0.00583	CcSEcCtD
Capreomycin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Capreomycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00425	0.00425	CcSEcCtD
Capreomycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00422	0.00422	CcSEcCtD
Capreomycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00391	0.00391	CcSEcCtD
Capreomycin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Capreomycin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Capreomycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Capreomycin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Capreomycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Capreomycin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Capreomycin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
